Toggle navigation
Home
Search
Services
Blog
Contact
About
Biologically Relevant Alpha Helix Stabilization
Erlanson, Daniel A.
Sunesis Pharmaceuticals, Inc., South San Francisco, CA, United States
Search 5 grants from Daniel Erlanson
Search grants from Sunesis Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
3/8 NADIA UO1 Adolescent Alcohol, Epigenetics and Behavioral Changes in Adulthood
Advanced Urinary Catheter for Reduction of Urinary Tract Infections and Improved Urologic Management
Drosophila Immune Response
Structural Studies of E. coli DNA Topoisomerase I
Statistical Methods for Detection of Primordial Gravitational Waves
Recently added grants:
Measure the metabolic and genetic factors that determine M. Tuberculosis
Forum on Microbial Threats
Functional analysis of a Group A streptococcal locus important for fitness in soft tissue
Administrative Core
Human Subjects Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
7F32GM019454-02
Application #
2906476
Study Section
Physical Biochemistry Study Section (PB)
Program Officer
Lohrey, Nancy
Project Start
1998-12-21
Project End
Budget Start
1998-12-21
Budget End
1999-03-08
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Sunesis Pharmaceuticals, Inc.
Department
Type
DUNS #
City
South San Francisco
State
CA
Country
United States
Zip Code
94080
Comments
Be the first to comment on Daniel Erlanson's grant